Pharma's Almanac: Nice Insight's Content Community

Articles
Expert Interviews
Roundtable
Press Releases
Videos

Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing

Biologics – Large Molecules

Sort By

Nice Insight is the market research division of That’s Nice LLC, the leading marketing agency serving life sciences.

Explore

About Us
Nice Insight
That's Nice

Reach Our Team

Contact Us
Advertise

My Account

Login/Sign up

Site

Privacy Policy
Terms And Conditions

© 2025 PHARMA’S ALMANAC. All rights reserved.

1 / 1

1 / 1

What do you see as the next big modality in biologics, and what factors are driving innovation in this space?

Next-Gen Biologics

What do you see as the next big modality in biologics, and what factors are driving innovation in this space?

Pharma's Almanac

PAO-04-25-RT-01May 01, 2025

Biosimilars Through the Years: Transforming Access and Cost in Biologics

Biosimilars

Biosimilars Through the Years: Transforming Access and Cost in Biologics

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-25-30-01Mar 02, 2025

Personalized Medicine and the CDMO: Adapting to a New Era of Healthcare

Personalized

Personalized Medicine and the CDMO: Adapting to a New Era of Healthcare

Ola Tuvesson; Isa Lindgren, Ph.D.

NorthX Biologics

PAO-01-25-CL-09Feb 14, 2025

AI Implementation to Enhance Quality

AI

AI Implementation to Enhance Quality

Seongil Cho; Hyeokgeon Kwon; Kisung Shim

Samsung Biologics

PAO-12-24-CL-5Dec 13, 2024